X0306 4 2016-02-26 0 0001631650 Aimmune Therapeutics, Inc. AIMT 0001648920 Rozenman Mary M. C/O AIMMUNE THERAPEUTICS, INC. 8000 MARINA BOULEVARD, SUITE 300 BRISBANE CA 94005-1884 0 1 0 0 See Remarks Stock Option (right to buy) 16.93 2016-02-26 4 A 0 80000 0.00 A 2026-02-26 Common Stock 80000 80000 D The shares subject to the option will vest and become exercisable as to one-forty-eighth (1/48th) of the total number of shares subject to the option in successive, equal monthly installments measured from February 26, 2016, subject to the Reporting Person's continued service relationship with the Issuer on each such vesting date. Senior VP, Corporate & Commercial Development /s/ Warren L. DeSouza, as Attorney-in-Fact for Mary M. Rozenman 2016-02-26